317 related articles for article (PubMed ID: 21251634)
1. Incidence, predictors, management, immediate and long-term outcomes following grade III coronary perforation.
Al-Lamee R; Ielasi A; Latib A; Godino C; Ferraro M; Mussardo M; Arioli F; Carlino M; Montorfano M; Chieffo A; Colombo A
JACC Cardiovasc Interv; 2011 Jan; 4(1):87-95. PubMed ID: 21251634
[TBL] [Abstract][Full Text] [Related]
2. Coronary perforation: an inconvenient complication.
Eeckhout E; De Palma R
JACC Cardiovasc Interv; 2011 Jan; 4(1):96-7. PubMed ID: 21251635
[No Abstract] [Full Text] [Related]
3. Coronary perforation in the drug-eluting stent era: incidence, risk factors, management and outcome: the UK experience.
Hendry C; Fraser D; Eichhofer J; Mamas MA; Fath-Ordoubadi F; El-Omar M; Williams P
EuroIntervention; 2012 May; 8(1):79-86. PubMed ID: 22580251
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics and Management of Coronary Artery Perforations: A Single-Center 11-Year Experience and Practical Overview.
Lemmert ME; van Bommel RJ; Diletti R; Wilschut JM; de Jaegere PP; Zijlstra F; Daemen J; Van Mieghem NM
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939719
[TBL] [Abstract][Full Text] [Related]
5. Indications and immediate and long-term results of a novel pericardium covered stent graft: Consecutive 5 year single center experience.
Secco GG; Serdoz R; Kilic ID; Caiazzo G; Mattesini A; Parisi R; De Luca G; Pistis G; Marino PN; Di Mario C
Catheter Cardiovasc Interv; 2016 Mar; 87(4):712-9. PubMed ID: 26541909
[TBL] [Abstract][Full Text] [Related]
6. Incidence, Management, Immediate and Long-Term Outcome of Guidewire and Device Related Grade III Coronary Perforations (from G3CAP - Cardiogroup VI Registry).
Cerrato E; Pavani M; Barbero U; Colombo F; Mangieri A; Ryan N; Quadri G; Tomassini F; Presutti DG; Calcagno S; Franzè A; Bellini B; D'Ascenzo F; Ielasi A; De Benedictis M; Azzalini L; Mancone M; Escaned J; Montorfano M; Latib A; Varbella F;
Am J Cardiol; 2021 Mar; 143():37-45. PubMed ID: 33387472
[TBL] [Abstract][Full Text] [Related]
7. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of patients who undergo percutaneous coronary intervention with covered stents for coronary perforation: A systematic review and pooled analysis of data.
Nagaraja V; Schwarz K; Moss S; Kwok CS; Gunning M
Catheter Cardiovasc Interv; 2020 Dec; 96(7):1360-1366. PubMed ID: 31850685
[TBL] [Abstract][Full Text] [Related]
9. Coronary Perforation Complicating Percutaneous Coronary Intervention in Patients With a History of Coronary Artery Bypass Surgery: An Analysis of 309 Perforation Cases From the British Cardiovascular Intervention Society Database.
Kinnaird T; Anderson R; Ossei-Gerning N; Cockburn J; Sirker A; Ludman P; de Belder M; Johnson TW; Copt S; Zaman A; Mamas MA;
Circ Cardiovasc Interv; 2017 Sep; 10(9):. PubMed ID: 28916604
[TBL] [Abstract][Full Text] [Related]
10. Sex-based differences in clinical and angiographic outcomes in patients with ST-elevation myocardial infarction treated with concomitant use of glycoprotein IIb/IIIa inhibitors.
Kralev S; Hennig O; Lang S; Kälsch T; Borggrefe M; Dempfle CE; Süselbeck T
Cardiol J; 2010; 17(6):580-6. PubMed ID: 21154260
[TBL] [Abstract][Full Text] [Related]
11. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
[TBL] [Abstract][Full Text] [Related]
12. Short-Term and Long-Term Outcomes After Polytetrafluoroethylene-Covered Stent Implantation for the Treatment of Coronary Perforation.
Kawamoto H; Tanaka K; Ruparelia N; Takagi K; Yabushita H; Watanabe Y; Mitomo S; Matsumoto T; Naganuma T; Fujino Y; Ishiguro H; Tahara S; Kurita N; Nakamura S; Hozawa K; Nakamura S
Am J Cardiol; 2015 Dec; 116(12):1822-6. PubMed ID: 26602072
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of polytetrafluoroethylene-covered stents implanted during percutaneous coronary intervention for management of acute coronary perforation.
Copeland KA; Hopkins JT; Weintraub WS; Rahman E
Catheter Cardiovasc Interv; 2012 Jul; 80(1):53-7. PubMed ID: 21953680
[TBL] [Abstract][Full Text] [Related]
14. Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Welsh RC; Granger CB; Westerhout CM; Blankenship JC; Holmes DR; O'Neill WW; Hamm CW; Van de Werf F; Armstrong PW;
JACC Cardiovasc Interv; 2010 Mar; 3(3):343-51. PubMed ID: 20298996
[TBL] [Abstract][Full Text] [Related]
15. Incidence, predictors, management and outcomes of coronary perforations.
Shaukat A; Tajti P; Sandoval Y; Stanberry L; Garberich R; Nicholas Burke M; Gössl M; Henry T; Mooney M; Sorajja P; Traverse J; Bradley SM; Brilakis ES
Catheter Cardiovasc Interv; 2019 Jan; 93(1):48-56. PubMed ID: 30312992
[TBL] [Abstract][Full Text] [Related]
16. Successful management of a distal vessel perforation through a single 8-French guide catheter: Combining balloon inflation for bleeding control with coil embolization.
Tarar MN; Christakopoulos GE; Brilakis ES
Catheter Cardiovasc Interv; 2015 Sep; 86(3):412-6. PubMed ID: 25854795
[TBL] [Abstract][Full Text] [Related]
17. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
[TBL] [Abstract][Full Text] [Related]
18. Incidence, predictors, morphological characteristics, and clinical outcomes of stent edge dissections detected by optical coherence tomography.
Chamié D; Bezerra HG; Attizzani GF; Yamamoto H; Kanaya T; Stefano GT; Fujino Y; Mehanna E; Wang W; Abdul-Aziz A; Dias M; Simon DI; Costa MA
JACC Cardiovasc Interv; 2013 Aug; 6(8):800-13. PubMed ID: 23871510
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G
JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029
[TBL] [Abstract][Full Text] [Related]
20. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.
Lee MS; Sillano D; Latib A; Chieffo A; Zoccai GB; Bhatia R; Sheiban I; Colombo A; Tobis J
Catheter Cardiovasc Interv; 2009 Jan; 73(1):15-21. PubMed ID: 19089930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
